ArticleInternational journal of biological sciences2024

High-Throughput Screening of an FDA-Approved Compound Library Reveals a Novel GAS6 Receptor Agonist for Therapeutic Intervention in Septic Myocardial and microvascular Injury via Modulation of Danger-Associated Molecular Patterns.

Haowen Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.